Envestnet Asset Management
AVXL icon

Envestnet Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Envestnet Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Buy
146,330
+17,155
+13% +$50.8K ﹤0.01% 4280
2026
Q1 		$397K Buy
129,175
+41,501
+47% +$180K ﹤0.01% 4092
2025
Q4 		$312K Buy
87,674
+27,731
+46% +$170K ﹤0.01% 4014
2025
Q3 		$533K Buy
59,943
+10,369
+21% +$105K ﹤0.01% 3718
2025
Q2 		$457K Sell
49,574
-3,428
-6% -$29.3K ﹤0.01% 3760
2025
Q1 		$455K Sell
53,002
-6,064
-10% -$57.3K ﹤0.01% 3686
2024
Q4 		$634K Buy
59,066
+20,771
+54% +$160K ﹤0.01% 3449
2024
Q3 		$218K Buy
+38,295
New +$221K ﹤0.01% 3985

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management's AVXL Position: Q2 2026 in Review

Envestnet Asset Management increased its Anavex Life Sciences (AVXL) stake by 13% in Q2 2026, buying an estimated $50.8K and bringing the position to 146,330 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #4280.

Envestnet Asset Management first reported a position in AVXL in Q3 2024 and has held it in 8 quarters since. The position peaked at $634K in Q4 2024. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Envestnet Asset Management held 146,330 shares of Anavex Life Sciences worth $379K as of Q2 2026.
  • Envestnet Asset Management bought 17,155 Anavex Life Sciences shares in Q2 2026, an estimated $50.8K.
  • Anavex Life Sciences made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4280 holding.
  • Envestnet Asset Management first reported a position in Anavex Life Sciences in Q3 2024 and has held it in 8 quarters since.
  • Envestnet Asset Management's Anavex Life Sciences position peaked at $634K in Q4 2024.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.